检索结果-南通市图书馆

detection of an anti-angina therapeutic module in the effective population treated by a multi-target drug Danhong injection:a randomized trial

在线全文

学校读者我要写书评

暂无评论

Signal Transduction and Targeted Therapy 2021年第10期6卷 3009-3018页

作者： Jun liu Dan-Dan Li Wei Dong Yu-Qi liu Yang Wu Da-Xuan Tang Fu-Chun zhang Meng qiu Qi Hua Jing-Yu He Jun Li Bai Du Ting-Hai Du Lin-Lin Niu Xue-Jun Jiang Bo Cui Jiang-Bin chen Yang-Gan Wang Hai-Rong Wang Qin Yu Jing He Yi-Lin Mao xiao-Fang Bin Yue deng Yu-Dan tian Qing-Hua Han Da-Jin liu Li-Qin Duan Ming-Jun Zhao Cui-Ying zhang Hai-Ying Dai Ze-Hua Li Ying xiao You-Zhi Hu xiao-Yu Huang Kun Xing Xin Jiang Chao-feng liu Jing An feng-Chun Li Tao Tao Jin-Fa Jiang Ying Yang Yao-Rong Dong Lei zhang guang Fu Ying Li Shu-Wei Huang Li-Ping Dou Lan-Jun Sun Ying-Qiang Zhao Jie Li Yun Xia Jun liu Fan liu Wen-Jin He Ying Li Jian-Cong Tan Yang Lin Ya-Bin Zhou Jian-Fei Yang Guo-Qing Ma Hui-Jun chen He-Ping liu Zong-Wu liu Jian-Xiong liu xiao-Jia Luo xiao-Hong Bin Ya-Nan Yu Hai-Xia Dang Bing Li Fei Teng Wang-Min Qiao xiao-Long Zhu Bing-Wei chen Qi-guang chen Chun-Ti Shen Yong-Yan Wang Yun-Dai chen Zhong Wang Institute of Basic Research in Clinical Medicine China Academy of Chinese Medical SciencesBeijingChina department of Cardiology Chinese PLA General HospitalBeijingChina department of Cardiology Dongfang Hospital Affiliated to Beijing University of Chinese MedicineBeijingChina department of Geratology Peking University Third HospitalBeijingChina department of Cardiology Xuan Wu HospitalCapital Medical UniversityBeijingChina department of Cardiology Guang'anmen HospitalChina Academy of Chinese Medical SciencesBeijingChina department of Cardiology First Affiliated Hospital of Henan University of Chinese MedicineZhengzhouHenanChina department of Cardiology Wuhan University Renmin HospitalWuhanHubeiChina department of Cardiology Wuhan University Zhongnan HospitalWuhanHubeiChina Affiliated Zhongshan Hospital of Dalian University DalianLiaoningChina department of Cardiology Second Affiliated Hospital to Hunan University of Chinese MedicineChangshaHunanChina department of Cardiology First Affiliated Hospital to Changchun University of Chinese MedicineChangchunJilinChina department of Cardiology First Affiliated Hospital to Shanxi Medical UniversityTaiyuanShanxiChina department of Cardiology Affiliated Hospital of Shanxi University of Chinese MedicineXianyangShanxiChina department of Cardiology Changsha Central HospitalChangshaHunanChina department of Cardiology Hubei Provincial Hospital of Traditional Chinese MedicineWuhanHubeiChina department of Cardiology Shanxi Provincial People's HospitalXi'anShanxiChina department of Cardiology Shanxi Province Hospital of Traditional Chinese MedicineXi'anShanxiChina department of Cardiology Xi'an City Hospital of Traditional Chinese MedicineXi'anShanxiChina department of Cardiology Shanghai Tongji HospitalShanghaiChina department of Cardiology Shanghai Municipal Hospital of Traditional Chinese MedicineShanghaiChina department of Cardiology The First Hospital of ChangshaChangshaHunanChina department of Cardiology Xinhua Hospi

It's a challenge for detecting the therapeutic targets of a polypharmacological drug from variations in the responsed networks in thedfferentiated populations with complex diseases,as stable coronary heart ***,in an adaptive,31-center,randomized,double-blind trial invoving 920 patients with moderate symptomatic stable angina treated by 14-day Danhong injection(DHI),a kind of polyphamacological drug with high quality control,or placebo(0.9%saline),with 76-day following-up,we firstly confrmed that DHl couldincrease the proportion of patients with clinically significant changes on angina-frequency assessed by Seattle Angina Questionnaire(ASAQ-AF220)(12.78%at Day 30,95%confidence interval[C]5.86-19.71%,P=0.0003,13.82%at Day 6C0,95%CI 6.82-20.82%,P=0.0001and 8.95%at Day 90,95%CI 2.06-15.85%,P=0.01).We also found that there were no significant differences in new-onset major vascularevents(P=0.8502)and serious adverse events(P=0.9105)between DHl and *** performing the RNA sequencing in 62 selectedpatients,we developed a systemic modular approach tp identfy differentilly expressed modules(deMs)of DHI with the Z_(summay)valueless than 0 compared with the control group,calculated by weighted gene co-expression network analysis(WGCNA),and sketched out thebasic framework on a modular map with 25 functional modules targeted by ***,the effective therapeutic module(ETM),defined as the highest corelation value with the phenotype alteration(SAQ-AF,the change in SAQ-AF at Day 30 from baseline)calculatedby WGCNA,was identifed in the population with the best effect(ASAQ-AF240),which is related to anticoagulation and regulation ofcholesterol *** assessed the modular flexbility of this ETM using the global topological D value based on Euclidean distance,which is corelated with phenotype alteration(r^(2):0.8204,P=0.019)by linear *** study identified the ant-angina therapeuticmodule in the effective population treated by the multi-target

关键词： angina injection sketch

The first data release(DR1) of the LAMOST regular survey

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Research in Astronomy and Astrophysics 2015年第8期15卷 1095-1124页

作者： A-Li Luo Yong-Heng Zhao Gang Zhao Li-Cai deng xiao-Wei liu Yi-Peng Jing Gang Wang Hao-Tong zhang Jian-Rong Shi Xiang-Qun Cui Yao-Quan Chu Guo-Ping Li Zhong-Rui Bai Yue Wu Yan Cai Shu-Yun Cao Zi-Huang Cao Jeffrey L.Carlin Hai-Yuan chen Jian-Jun chen Kun-Xin chen Li chen Xue-Lei chen xiao-Yan chen Ying chen Norbert Christlieb Jia-Ru Chu chen-Zhou Cui Yi-Qiao Dong Bing Du Dong-Wei Fan Lei feng Jian-Ning Fu Peng Gao Xue-Fei Gong Bo-Zhong Gu Yan-Xin Guo Zhan-Wen Han Bo-Liang He Jin-Liang Hou Yong-Hui Hou Wen Hou Hong-Zhuan Hu Ning-Sheng Hu Zhong-Wen Hu Zhi-Ying Huo Lei Jia Fang-Hua Jiang Xiang Jiang Zhi-Bo Jiang Ge Jin xiao Kong Xu Kong Ya-Juan Lei Ai-Hua Li chang-Hua Li guang-Wei Li Hai-Ning Li Jian Li Qi Li Shuang Li Sha-Sha Li Xin-Nan Li Yan Li Yin-Bi Li Ye-Ping Li Yuan Liang Chien-cheng Lin Chao liu Gen-Rong liu Guan-Qun liu Zhi-Gang liu Wen-Zhi Lu Yu Luo Yin-Dun Mao Heidi Newberg Ji-Jun Ni Zhao-Xiang Qi Yong-Jun Qi Shi-Yin Shen Huo-Ming Shi Jing Song Yi-Han Song Ding-Qiang Su Hong-Jun Su Zheng-Hong Tang Qing-Sheng Tao Yuan tian Dan Wang Da-Qi Wang feng-Fei Wang Guo-Min Wang Hai Wang Hong-Chi Wang Jian Wang Jia-Ning Wang Jian-Ling Wang Jian-Ping Wang Jun-Xian Wang Lei Wang Meng-Xin Wang Shou-Guan Wang Shu-Qing Wang Xia Wang Ya-Nan Wang You Wang Yue-Fei Wang You-Fen Wang Peng Wei Ming-Zhi Wei Hong Wu Ke-Fei Wu Xue-Bing Wu Yu-Zhong Wu xiao-Zheng Xing Ling-Zhe Xu Xin-Qi Xu Yan Xu Tai-Sheng Yan de-Hua Yang Hai-feng Yang Hui-Qin Yang Ming Yang Zheng-qiu Yao Yong Yu Hui Yuan Hai-Bo Yuan Hai-Long Yuan Wei-Min Yuan Chao Zhai En-Peng zhang Hua-Wei zhang Jian-Nan zhang Li-Pin zhang Wei zhang Yong zhang Yan-Xia zhang Zheng-Chao zhang Ming Zhao Fang Zhou Xu Zhou Jie Zhu Yong-tian Zhu Si-cheng Zou Fang Zuo National Astronomical Observatories Chinese Academy of Sciences department of Astronomy Peking University Shanghai Astronomical Observatory Chinese Academy of Sciences Nanjing Institute of Astronomical Optics & Technology National Astronomical ObservatoriesChinese Academy of Sciences University of Science and Technology of China department of Physics Applied Physics and AstronomyRensselaer Polytechnic InstituteTroyNY 12180USA department of Physics and Astronomy Earlham CollegeRichmondIN 47374USA Universitt Heidelberg Zentrum für AstronomieLandessternwarteKnigstuhl 1269117 HeidelbergGermany department of Astronomy Beijing Normal University Yunnan Observatories Chinese Academy of Sciences Purple Mountain Observatory Chinese Academy of Sciences

The Large sky Area Multi-Object Fiber Spectroscopic Telescope（LAMOST） general survey is a spectroscopic survey that will eventually cover approximately half of the celestial sphere and collect 10 million spectra of stars, galaxies and QSOs. Objects in both the pilot survey and the first year regular survey are included in the LAMOST DR1. The pilot survey started in October 2011 and ended in June 2012, and the data have been released to the public as the LAMOST Pilot Data Release in August 2012. The regular survey started in September 2012, and completed its first year of operation in June 2013. The LAMOST DR1 includes a total of 1202 plates containing 2 955 336 spectra, of which 1 790 879 spectra have observed signalto-noise ratio（SNR） ≥ 10. All data with SNR ≥ 2 are formally released as LAMOST DR1 under the LAMOST data policy. This data release contains a total of 2 204 696 spectra, of which 1 944 329 are stellar spectra, 12 082 are galaxy spectra and 5017 are quasars. The DR1 not only includes spectra, but also three stellar catalogs with measured parameters： late A,FGK-type stars with high quality spectra（1 061 918 entries）, A-type stars（100 073 entries）, and M-type stars（121 522 entries）. This paper introduces the survey design, the observational and instrumental limitations, data reduction and analysis, and some caveats. A description of the FITS structure of spectral files and parameter catalogs is also provided.

关键词： techniques: spectroscopic survey—data release—catalog

Consensus statement on layout and delivery of automatic external defibrillator in China

在线全文

学校读者我要写书评

暂无评论

Journal of Hainan Medical University 2020年第15期26卷 18-23页

作者： Yu Cao Song chen Yan-Fen Chai xiao-Hui chen Yu-Guo chen Shao-Wen cheng Wen-Wei cheng Bang-Han Ding Yang deng Jie Fu Bang-Jiang Fang Mai-Ying Fan Li Gui Ping Gong Wei Guo Shu-Bin Guo Liang Huang Ji-Yuan Han Zhong Ji Xian-Fei Ji Xin-Cai Ji Hong-Xu Jin Xin-Jun Jiang Wang-Xiang Jiang Jia-Liang liu xiao-Ran liu Zhi liu Chuan-Zhu Lv feng Lu Tan-Shi Li Xin Li Yong Li Shang-Lun Li Shuang-Ming Li xiao-Gang Li Bao-Jun Li Pei-Wu Li Chun-Sheng Li Zhi-Jun Li chang-Luo Li Xiang-Min Li Yin-Ping Li Zong-Jun Lu Zu-Xun Lu Zhong-qiu Lu Zhi-Qian Luo xiao-Xing Liao Jian-Bo Lei Tao Ma Yu Ma Yue-feng Ma Qing-Bian Ma Lin-Hao Ma Jun-Qi Ma Shi-Nan Nie Jie-Miao Ou-Yang Peng Peng Qiao Pei Shu-Ming Pan Guo-Zhong Qing Li-Jie Qin Wu-Ying Qiao Fei Shao Wei Song Xing-Yue Song Zhen-Ju Song Rong-Ju Sun de-Ya Shang Du-Juan Sha Gui-Lan Tao Guo-Gang tian Ying-Ping tian Jian-guang tian Chao-Yang Tong Zi-Ren Tang Meng-Xiong Tang Guo-Ping Wu Zhi Wan Tao Wang Xin Wang Peng Wang Zhong Wang Tong Wang Ri-Xing Wang Yi-Xin Wang xiao-Dan Wang Ling Wu Wei Wei Hua Xiang feng Xu Jun Xu Jie Xu Miao-Rong Xie Shuo-Gui Xu Tie Xu feng Yu Wen Yi Li-Shan Yang Shi-Jiao Yan Jin-Jian Yao Shou-Chun Yan Xue-Zhong Yu Xian-Zhi Ye Xian-Liang Yan Fu-Bing Zhou Rong-Bin Zhou Ming Zhou Qiang Zhou Jin Zhou Ping Zhou chang-Ju Zhu Hua-Dong Zhu Ji-Hong Zhu Hong zhang Mao zhang Hua zhang Na zhang Guo-Qiang zhang Guo-Xiu zhang Jin-Song zhang Wen-Wu zhang Wen-Zhong zhang Jian-feng zhang Yi-Min Zhu Jun Zeng Yuan Zheng Zhi-Jie Zheng Shen Zhao Yan Zhao Min Zhao Bin Zhao xiao-Dong Zhao xiao-Jing Zhao Hong-Ke Zeng Sheng-Qiang Zou The Chinese Society of Emergency Medicine Research Unit of Island Emergency Medicine Chinese Academy of Medical SciencesHainan Medical University Key Laboratory of Emergency and Trauma of Ministry of Education Hainan Medical UniversityHaikouHainanChina Emergency and Trauma College Hainan Medical UniversityHaikouHainanChina department of Emergency Hainan Clinical Research Center for Acute and Critical DiseasesThe Second Affiliated Hospital of Hainan Medical UniversityHaikouHainanChina Key Laboratory of Hainan Trauma and Disaster Rescue Key Laboratory of Trauma of Hainan Medical University

*** Sudden cardiac death(SCD)refers to sudden death due to a variety of cardiac *** is manifested as a sudden loss of consciousness,cardiac arrest,and respiratory arrest and generally shows early symptoms that are atypical and not easily detected[1].According to a recent study,nearly 544000 patients suffer from SCD every year in China[2].

关键词： cardiac death respiratory

CEPC Technical design Report

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Radiation detection Technology and Methods 2024年第1期8卷 I0003-I0016,1-1091页

作者： Waleed Abdallah Tiago Carlos Adorno de Freitas Konstantin Afanaciev Shakeel Ahmad Ijaz Ahmed xiaocong Ai Abid Aleem Wolfgang Altmannshofer Fabio Alves Weiming An Rui An Daniele Paolo Anderle Stefan Antusch Yasuo Arai Andrej Arbuzov Abdesslam Arhrib Mustafa Ashry Sha Bai Yu Bai Yang Bai Vipul Bairathi Csaba Balazs Philip Bambade Yong Ban Tripamo Bandyopadhyay Shou-Shan Bao desmond P.Barber Ayse Bat Varvara Batozskaya Subash Chandra Behera Alexander Belyaev Michele Bertucci xiao-Jun Bi Yuanjie Bi tianjian Bian Fabrizio Bianchi Thomas Biekotter Michela Biglietti Shalva Bilanishvili deng Binglin denis Bodrov Anton Bogomyagkov Serge Bondarenko Stewart Boogert Maarten Boonekamp Marcello Borri Angelo Bosotti Vincent Boudry Mohammed Boukidi Igor Boyko Ivanka Bozovic Giuseppe Bozzi Jean-Claude Brient Anastasiia Budzinskaya Masroor Bukhari Vladimir Bytev Giacomo Cacciapaglia Hua Cai Wenyong Cai Wujun Cai Yijian Cai Yizhou Cai Yuchen Cai Haiying Cai Huacheng Cai Lorenzo Calibbi Junsong Cang Guofu Cao Jianshe Cao Antoine Chance Xuejun chang Yue chang Zhe chang Xinyuan chang Wei Chao Auttakit Chatrabhuti Yimin Che Yuzhi Che Bin chen Danping chen Fuqing chen Fusan chen Gang chen Guoming chen Hua-Xing chen Huirun chen Jinhui chen Ji-Yuan chen Kai chen Mali chen Mingjun chen Mingshui chen Ning chen Shanhong chen Shanzhen chen Shao-Long chen Shaomin chen Shiqiang chen tianlu chen Wei chen Xiang chen xiaoyu chen Xin chen Xun chen Xurong chen Ye chen Ying chen Yukai chen Zelin chen Zilin chen Gang chen Boping chen Chunhui chen Hok Chuen cheng Huajie cheng Shan cheng Tongguang cheng Yunlong Chi Pietro Chimenti Wen Han Chiu Guk Cho Ming-Chung Chu xiaotong Chu Ziliang Chu Guglielmo Coloretti Andreas Crivellin Hanhua Cui xiaohao Cui Zhaoyuan Cui Brunella D'Anzi Ling-Yun Dai Xinchen Dai Xuwen Dai Antonio de Maria Nicola de Filippis Christophe de La Taille Francesca de Mori Chiara de Sio Elisa del Core Shuangxue deng Wei-tian deng Zhi deng Ziyan deng Bhupal dev Tang dewen Biagio Di Micco Ran Ding Siqin Dingl Yadong Ding Haiyi Dong Jianin AGH University of Science and Technology Faculty of Physics and Applied Computer ScienceKrakow Anhui University HefeiAnhui Applied Physics department Federal Urdu University of ArtsScience and TechnologyIslamabad Banaras Hindu University Institute of ScienceVaranasi Bandirma Onyedi Eylul University Bandirma Beihang University Beijing Beijing Computational Science Research Center Beijing Beijing Conveyi LTD Beijing Beijing Glass Research Institute Co. LtdBeijing Beijing Institute of Technology Beijing Beijing Normal University Beijing Brown University ProvidenceRI Budker Institute of Nuclear Physics Novosibirsk Cadi Ayyad University Laboratory of Fundamental and Applied PhysicsPolydisciplinary FacultyMarrakech Cairo University Giza Center for Theory and Computation National Tsing Hua UniversityHsinchu Central China Normal University WuhanHubei Central South University ChangshaHunan Centro de Fisica Teorica de Particulas Universidade Tecnica de LisboaLisboa chengdu KaitengSifang Digital Radio&TV Equipment Co. LtdChengduSichuan China academy of engineering physics MianyangSichuan China building materials academy Beijing China Center of Advanced Science and Technology Beijing China Institute of Atomic Energy Beijing China Jiliang University HangzhouZhejiang China Nuclear Instrument CO. LTDBeijing China University of Geosciences Beijing China University of Geosciences WuhanHubei China University of Mining and Technology XuzhouJiangsu China West Normal University NanchongSichuan Chongqing University Department of PhysicsChongqing Chulalongkorn University Bangkok City University of Hong Kong Department of PhysicsHong Kong Cockcroft Institute Daresbury Cornell University IthacaNY CPPM(AMU/IPhU&CNRS/INP) Marseille Dalian Minzu University DalianLiaoning Dalian University of Technology Department of PhysicsDalian deutsches Elektronen-Synchrotron deSY Hamburg Dzhelepov Laboratory of Nuclear Problems of Joint Institute for Nuclear Research(DLNP JINR) Dubna East China University Of Science And Technol

The Circular Electron Positron Collider(CEPC)is a large scientific project initiated and hosted by China,fostered through extensive collaboration with international *** complex comprises four accelerators:a 30 GeV Linac,a 1.1 GeV Damping Ring,a Booster capable of achieving energies up to 180 GeV,and a Collider operating at varying energy modes(Z,W,H,and tt).The Linac and Damping Ring are situated on the surface,while the subterranean Booster and Collider are housed in a 100 km circumference underground tunnel,strategically accommodating future expansion with provisions for a potential Super Proton Proton Collider(SPPC).The CEPC primarily serves as a Higgs *** its baseline design with synchrotron radiation(SR)power of 30 MW per beam,it can achieve a luminosity of 5×10^(34)cm^(-2)s^(-1)per interaction point(IP),resulting in an integrated luminosity of 13 ab^(-1)for two IPs over a decade,producing 2.6 million Higgs *** the SR power to 50 MW per beam expands the CEPC's capability to generate 4.3 million Higgs bosons,facilitating precise measurements of Higgs coupling at sub-percent levels,exceeding the precision expected from the HL-LHC by an order of *** Technical design Report(TDR)follows the Preliminary Conceptual design Report(Pre-CDR,2015)and the Conceptual design Report(CDR,2018),comprehensively detailing the machine's layout,performance metrics,physical design and analysis,technical systems design,R&D and prototyping efforts,and associated civil engineering ***,it includes a cost estimate and a preliminary construction timeline,establishing a framework for forthcoming engineering design phase and site selection *** is anticipated to begin around 2027-2028,pending government approval,with an estimated duration of 8 *** commencement of experiments and data collection could potentially be initiated in the mid-2030s.

关键词： initiated exceeding precise

The DIRECT consortium and the REST-meta-MDD project:towards neuroimaging biomarkers of major depressive disorder

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Psychoradiology 2022年第1期2卷 32-42页

作者： xiao chen Bin Lu Hui-Xian Li Xue-Ying Li Yu-Wei Wang Francisco Xavier Castellanos Li-Ping Cao Ning-Xuan chen Wei chen Yu-Qi cheng Shi-Xian Cui Zhao-Yu deng Yi-Ru Fang Qi-Yong Gong Wen-Bin Guo Zheng-Jia-Yi Hu Li Kuang Bao-Juan Li Le Li Tao Li Tao Lian Yi-Fan Liao Yan-Song liu Zhe-Ning liu Jian-Ping Lu Qing-Hua Luo Hua-Qing Meng Dai-Hui Peng Jiang qiu Yue-Di Shen tian-Mei Si Yan-Qing Tang Chuan-Yue Wang Fei Wang Hua-Ning Wang Kai Wang Xiang Wang Ying Wang Zi-Han Wang xiao-Ping Wu Chun-Ming Xie guang-Rong Xie Peng Xie Xiu-feng Xu Hong Yang Jian Yang Shu-Qiao Yao Yong-Qiang Yu Yong-Gui Yuan Ke-Rang zhang Wei zhang Zhi-Jun zhang Jun-Juan Zhu Xi-Nian Zuo Jing-Ping Zhao Yu-feng Zang the DIRECT consortium Chao-Gan Yan CAS Key Laboratory of Behavioral Science Institute of PsychologyChinese Academy of SciencesBeijing 100101China International Big-Data Center for depression Research Chinese Academy of SciencesBeijing 100101China Magnetic Resonance Imaging Research Center Institute of PsychologyChinese Academy of SciencesBeijing 100101China department of Psychology University of Chinese Academy of SciencesBeijing 100049China Sino-Danish College University of Chinese Academy of SciencesBeijing 101408China Sino-Danish Center for Education and Research Graduate University of Chinese Academy of SciencesBeijing 101408China department of Child and Adolescent Psychiatry NYU Grossman School of MedicineNew YorkNY 10016USA Nathan Kline Institute for Psychiatric Research OrangeburgNew YorkNY 10962USA 9Affiliated Brain Hospital of Guangzhou Medical UniversityGuangzhou 510370China Capital Normal University Beijing 100089China department of Psychiatry Sir Run Run Shaw HospitalZhejiang University School of MedicineHangzhou 310020ZhejiangChina department of Psychiatry First Affiliated Hospital of Kunming Medical UniversityKunmingYunnan 650032China Shanghai Mental Health Center Shanghai Jiao Tong University School of MedicineShanghai 200030China Huaxi MR Research Center(HMRRC) Department of RadiologyWest China Hospital of Sichuan UniversityChengduSichuan 610044China Research Unit of Psychoradiology Chinese Academy of Medical SciencesChengduSichuan 610052China department of Psychiatry and National Clinical Research Center for Mental DisordersThe Second Xiangya Hospital of Central South UniversityChangsha 410011HunanChina department of Psychiatry The First Affiliated Hospital of Chongqing Medical UniversityChongqing 400042China Xijing Hospital of Air Force Military Medical University Xi’anShaanxi 710032China Center for Cognitive Science of Language Beijing Language and Culture UniversityBeijing 100083China Affiliated Mental Health Center&Hangzhou Seventh People’s Hospital Zhejiang University School of

despite a growing neuroimaging literature on the pathophysiology of major depressive disorder(MDD),repro-ducible findings are lacking,probably reflecting mostly small sample sizes and heterogeneity in analytic *** address these issues,the depression Imaging REsearch ConsorTium(DIRECT)was *** REST-meta-MDD project,pooling 2428 functional brain images processed with a standardized pipeline across all participating sites,has been the first effort from *** this review,we present an overview of the moti-vations,rationale,and principal findings of the studies so far from the REST-meta-MDD *** from the first round of analyses of the pooled repository have included alterations in functional connectivity within the default mode network,in whole-brain topological properties,in dynamic features,and in functional *** well-powered exploratory observations have also provided the basis for future longitudinal hypothesis-driven *** these fruitful explorations,DIRECT has proceeded to its second stage of data sharing that seeks to examine ethnicity in brain alterations in MDD by extending the exclusive Chinese original sample to other ethnic groups through international collaborations.A state-of-the-art,surface-based preprocessing pipeline has also been introduced to improve *** images from patients with bipolar disorder and schizophrenia will be included to identify shared and unique abnormalities across diag-nosis *** addition,large-scale longitudinal studies targeting brain network alterations following antidepressant treatment,aggregation of diffusion tensor images,and the development of functional magnetic resonance imaging-guided neuromodulation approaches are *** these endeavours,we hope to accelerate the translation of functional neuroimaging findings to clinical use,such as evaluating longitudinal effects of antidepressant medications and developing individualized

关键词： major depressive disorder DIRECT R-fMRI database neuroimaging

柳氮磺吡啶在我国类风湿关节炎患者的用药现况调查

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

北京大学学报（医学版） 2012年第2期44卷 188-194页

作者：刘田王秀茹安媛周云杉张晓盈段天骄朱佳鑫李晓峰王莉枝王彩虹王永福杨荣王国春卢昕朱平陈丽娜靳洪涛刘湘源孙琳陈海英崔刘福舒荣刘白鹭张卓莉李光韬李振彬杨静李俊芳贾彬张风肖陶杰梅韩淑玲林金盈韦美秋刘晓敏柯丹胡绍先叶丛杨岫岩李昊黄慈波高明赖蓓李兴福宋立军王轶王晓元穆荣苏茵栗占国北京大学人民医院风湿免疫科北京100044 北京大学首钢医院多顶街社区卫生中心全科山西医科大学第二医院风湿免疫科太原030001 包头医学院第一附属医院风湿免疫科包头014010 中日友好医院风湿免疫科北京100029 第四军医大学西京医院风湿免疫科西安710032 河北医科大学第二医院风湿免疫科石家庄050000 北京大学第三医院风湿免疫科北京100191 河北医科大学第三医院风湿免疫科石家庄050051 华北煤炭医学院附属开滦医院风湿免疫科唐山063000 北京大学第一医院风湿免疫科北京100034 白求恩国际和平医院风湿免疫科石家庄050082 河北邯郸中心医院风湿免疫科邯郸056001 河北省人民医院风湿免疫科石家庄050051 北京大学首钢医院风湿免疫科北京100144 广西壮族自治区人民医院风湿免疫科南宁530021 北京顺义区医院风湿免疫科北京101300 华中科技大学同济医学院附属同济医院风湿免疫科武汉430030 中山医科大学附属第一医院风湿免疫科广州510080 北京医院风湿免疫科北京100730 山东大学齐鲁医院风湿免疫科济南250012 兰州大学第二医院风湿免疫科兰州730030

目的:调查和分析类风湿关节炎(rheumatoid arthritis,RA)患者治疗中柳氮磺吡啶(sulphasalazine,SSZ)的使用及其不良反应发生情况。方法:采用流行病学现况调查的研究方法,对北京大学人民医院等全国21家三级甲等医院2009年7月至2010年12... 详细信息

目的:调查和分析类风湿关节炎(rheumatoid arthritis,RA)患者治疗中柳氮磺吡啶(sulphasalazine,SSZ)的使用及其不良反应发生情况。方法:采用流行病学现况调查的研究方法,对北京大学人民医院等全国21家三级甲等医院2009年7月至2010年12月于风湿免疫科门诊及病房就诊的1 096例RA患者进行问卷调查,并详细记录患者的一般资料和临床特点,分析其中160例使用SSZ患者的临床特点、副作用发生情况、SSZ使用现况及联合用药种类和时间等数据。结果:160例患者使用SSZ治疗,使用比例为14.6%。该组患者男女之比为1∶7,平均发病年龄为(46.1±15.0)岁,平均病程为(9.9±7.8)年。SSZ平均用量为(1.87±0.52)g/d,平均用药时间为(26.3±14.6)月。所有患者仅有17%(27/160)使用SSZ单药治疗,其余患者均曾联合应用其他缓解病情抗风湿药(diseasemodifying antirheumatic drugs,DMARDs),其中甲氨蝶呤(methotrexate,MTX)是最常应用的联合治疗药物,占63.1%,平均联合使用MTX时间(28.2±12.3)月;其次为来氟米特(36.2%)和羟氯喹(18.1%);SSZ+MTX是最常见的联合治疗方案(36.2%)。应用SSZ患者的疗效指标优于未应用者。调查时有41.9%(67/160)的患者曾使用SSZ治疗,但因药物不良反应或其他原因而停药。有17.5%(28/160)的患者因不良反应停药,其中因胃肠道反应停药比率(8.8%)最高,其次为皮疹(3.8%)和肝功能异常(3.1%)。结论:与其他国家相比,SSZ在我国应用率偏低,且平均用量上较临床规范用量偏小。SSZ治疗RA不良反应程度较轻,在临床应用中相对比较安全。

关键词：柳氮磺吡啶关节炎,类风湿横断面研究

我国类风湿关节炎患者应用肿瘤坏死因子抑制剂现况调查

在线全文

学校读者我要写书评

暂无评论

北京大学学报（医学版） 2012年第2期44卷 182-187页

作者：王秀茹苏茵安媛周云杉张晓盈段天骄朱佳鑫李小峰王彩虹王莉枝王永福杨荣王国春卢昕朱平陈丽娜王轶王晓元靳洪涛刘金婷陈海英魏平王俊祥刘湘源孙琳崔刘福舒荣刘白鹭张卓莉李光韬李振彬杨静李俊芳贾彬张风肖陶杰梅林金盈韦美秋刘晓敏柯丹胡绍先叶丛韩淑玲杨岫岩李昊黄慈波高明赖蓓李兴福宋立军穆荣栗占国北京大学人民医院风湿免疫科北京100044 北京大学首钢医院多顶街社区卫生中心全科山西医科大学第二医院风湿免疫科太原030001 包头医学院第一附属医院风湿免疫科包头014010 中日友好医院风湿免疫科北京100029 第四军医大学西京医院风湿免疫科西安710032 兰州大学第二医院风湿免疫科兰州730030 河北医科大学第二医院风湿免疫科石家庄050000 河北医科大学第三医院风湿免疫科石家庄050051 北京大学第三医院风湿免疫科北京100191 华北煤炭医学院附属开滦医院风湿免疫科唐山063000 北京大学第一医院风湿免疫科北京100034 白求恩国际和平医院风湿免疫科石家庄050082 河北邯郸中心医院风湿免疫科邯郸056001 河北省人民医院风湿免疫科石家庄050051 广西壮族自治区人民医院风湿免疫科南宁530021 北京顺义区医院风湿免疫科北京101300 华中科技大学同济医学院附属同济医院风湿免疫科武汉430030 北京大学首钢医院风湿免疫科北京100144 中山医科大学附属第一医院风湿免疫科广州510080 北京医院风湿免疫科北京100730 山东大学齐鲁医院风湿免疫科济南250012

目的:了解我国类风湿关节炎(rheumatoid arthritis,RA)患者应用肿瘤坏死因子(tumor necrosis factor,TNF)抑制剂的现状以及影响其应用的因素。方法:采用多中心现况调查问卷调查的方法,记录入选者的一般情况和应用TNF抑制剂的情况,计算... 详细信息

目的:了解我国类风湿关节炎(rheumatoid arthritis,RA)患者应用肿瘤坏死因子(tumor necrosis factor,TNF)抑制剂的现状以及影响其应用的因素。方法:采用多中心现况调查问卷调查的方法,记录入选者的一般情况和应用TNF抑制剂的情况,计算患者应用TNF抑制剂的费用,分析我国TNF抑制剂的应用现状及影响其应用的相关因素。结果:2009年7月至2010年11月期间,共有全国范围内的21家大型医院风湿免疫科就诊的1 095位RA患者完成问卷,其中112位患者应用了TNF抑制剂(infliximab,商品名类克或etanercept,商品名益赛普)进行治疗,占总研究人群的10.2%(其中益赛普81例,占7.4%;类克26例,占2.4%;两种制剂都用过者5例,占0.5%)。应用类克疗程<3个月及3～6个月者均为38.1%,益赛普疗程<3个月及3～6个月者分别占38.5%和25.0%。应用类克疗程<3个月、3～6个月及6～9个月者的健康评估问卷(health assessment question-naire,HAQ)评分分别为1.1、0.5、0.1,益赛普的相应评分分别为1.3、1.0、0.3。应用类克疗程<3个月、3～6个月及6～9个月的费用分别为24 525.0、69 300.0、96 800.0元,益赛普的费用分别为7 394.8、9 158.6、54 910.9元。应用类克疗程<3个月、3～6个月及6～9个月的患者的间接经济损失分别为365.6、0、158.9元,益赛普分别为2 158.4、288.5、180.1元。出现过敏和感染的比例在应用益赛普者均为3.5%,在应用类克者均为6.5%。Logistic回归分析显示,受教育程度是影响TNF抑制剂应用的主要相关因素。结论:在我国大型医院就诊的RA患者中约有10%应用过TNF抑制剂,其病情随应用TNF抑制剂的疗程延长而减轻,治疗总费用随用药疗程延长而增加,但间接经济损失随疗程延长而减少,主要不良反应为过敏和感染,受教育程度是影响其应用的主要相关因素。

关键词：关节炎,类风湿肿瘤坏死因子问卷调查药费支出

全国多中心类风湿关节炎冠心病危险因素的现况调查

在线全文

学校读者我要写书评

暂无评论

北京大学学报（医学版） 2012年第2期44卷 176-181页

作者：李春王秀茹唐熠达安媛周云杉郭时伟张晓盈段天骄朱佳鑫李晓峰王莉枝王彩虹王永福杨荣王国春卢昕朱平陈丽娜靳洪涛刘金婷刘湘源孙琳陈海英魏平王俊祥崔刘福舒荣刘白鹭张卓莉李光韬李振彬杨静李俊芳贾彬张风肖陶杰梅韩淑玲林金盈韦美秋刘晓敏柯丹胡绍先叶丛杨岫岩李昊黄慈波高明赖蓓李兴福宋立军王轶王晓元穆荣苏茵栗占国北京大学人民医院风湿免疫科北京100044 北京大学首钢医院多顶街社区卫生中心全科中国医学科学院北京协和医学院阜外心血管病医院心内科北京100037 山西医科大学第二医院风湿免疫科太原030001 包头医学院第一附属医院风湿免疫科包头014010 中日友好医院风湿免疫科北京100029 第四军医大学西京医院风湿免疫科西安710032 河北医科大学第二医院风湿免疫科石家庄050000 北京大学第三医院风湿免疫科北京100191 河北医科大学第三医院风湿免疫科石家庄050051 华北煤炭医学院附属开滦医院风湿免疫科唐山063000 北京大学第一医院风湿免疫科北京100034 白求恩国际和平医院风湿免疫科石家庄050082 河北邯郸中心医院风湿免疫科邯郸056001 河北省人民医院风湿免疫科石家庄050051 北京大学首钢医院风湿免疫科北京100144 广西壮族自治区人民医院风湿免疫科南宁530021 北京顺义区医院风湿免疫科北京101300 华中科技大学同济医学院附属同济医院风湿免疫科武汉430030 中山医科大学附属第一医院风湿免疫科广州510080 北京医院风湿免疫科北京100730 山东大学齐鲁医院风湿免疫科济南250012 兰州大学第二医院风湿免疫科兰州730030

目的:了解我国类风湿关节炎(rheumatoid arthritis,RA)患者冠心病(coronary artery disease,CAD)的患病情况并评估其发生的危险因素。方法:调查RA患者冠心病相关的临床资料,包括冠心病的患病情况、冠心病传统危险因素[糖尿病、高血压、... 详细信息

目的:了解我国类风湿关节炎(rheumatoid arthritis,RA)患者冠心病(coronary artery disease,CAD)的患病情况并评估其发生的危险因素。方法:调查RA患者冠心病相关的临床资料,包括冠心病的患病情况、冠心病传统危险因素[糖尿病、高血压、高血脂、吸烟及体重指数(BMI)]及RA临床表现[关节肿胀、疼痛、畸形数目,皮下结节数目,动态红细胞沉降率(erythrocyte sedimentation rate,ESR)、C反应蛋白(C-reactive protein,CRP)、类风湿因子(rheumatoid factor,RF)等]、关节功能状态评分及用药情况。对冠心病组及非冠心病组的危险因素、临床特点及用药情况等方面进行单因素比较及多因素Logistic回归分析。结果:共调查21家医院的960例RA患者,其中女性779人,男性181人,女∶男=4.3∶1,平均年龄(52.7±13.9)岁(11.0～86.0岁)。RA患者冠心病的患病率为3.5%(34/960),其中合并超重和肥胖者占35.1%(377/960)、吸烟者占12.3%(118/960)、高血压者占17.0%(163/960)、糖尿病者占7.7%(74/960)、高胆固醇血症者占0.4%(4/960)、脑血管病者占3.0%(29/960)。冠心病组与非冠心病组相比,年龄高[(64.7±9.3)岁vs.(52.3±14.0)岁,P<0.001]、皮下结节数目多(14.7%vs.3.1%,P=0.005)、肺间质病变发生率高(17.6%vs.7.0%,P=0.034)、羟氯喹(hydroxychloroquine,HCQ)使用比例低(5.9%vs.22.6%,P=0.021)、糖尿病及高血压患病率高(29.4%vs.7.0%,P<0.001;38.2%vs.16.2%,P=0.001),而受检时关节畸形数目、RF水平及糖皮质激素的使用、高胆固醇血症患病率及BMI与冠心病发生无关。经多元Logistic回归分析,高龄、合并糖尿病及高血压为RA合并冠心病的独立危险因素,使用HCQ为RA合并冠心病的保护因素。结论:RA患者冠心病的患病率为3.5%。高龄、合并糖尿病及高血压为其独立危险因素,合并使用HCQ为其保护因素。

关键词：关节炎,类风湿冠心病危险因素患病率

球囊扩张或血管支架在急性大脑中动脉M1段机械取栓治疗失败患者中的有效性和安全性对比研究

在线全文

学校读者我要写书评

暂无评论

中国医学前沿杂志（电子版） 2019年第2期11卷 73-79页

作者：岳成松资文杰邱忠明李凤利杨峻刘瀚圣刘文华黄文国时忠华杨世泉邱涛张帅曾国勇周宏斌王琰艾志斌刘勇胡伟万跃温昌明田喜光周志明王振李冰陈忠伦吴德平陈路明余鹏霄罗伟东刘帅龚自力中国人民解放军陆军军医大学第二附属医院神经内科重庆400037 武汉市第一医院神经内科武汉430022 茂名市中医院神经内科广东茂名525000 中国人民解放军第904医院神经外科江苏无锡214008 中国人民解放军第902医院神经内科安徽蚌埠233010 自贡市第一人民医院神经内科四川自贡643000 扬州市第一人民医院神经内科江苏扬州225001 赣州市人民医院神经内科江西赣州341001 襄阳市中心医院神经内科湖北襄阳441021 成都市第五人民医院神经内科成都611130 十堰市太和医院神经内科湖北十堰442008 六安市人民医院神经内科安徽六安237016 安徽省立医院神经内科合肥230001 湖北省第三人民医院神经内科武汉430032 南阳市中心医院神经内科河南南阳473003 武警广东省总队医院神经内科广州510507 皖南医学院弋矶山医院神经内科安徽芜湖241001 长沙市中心医院神经内科长沙410004 烟台毓璜顶医院神经内科山东烟台264099 绵阳市中心医院神经内科四川绵阳621000

目的探讨球囊扩张或血管支架补救治疗对急性大脑中动脉M1段机械取栓治疗失败患者的安全性和有效性,并分析患者预后的影响因素。方法回顾性分析2014年1月至2018年6月中国人民解放军陆军军医大学第二附属医院综合卒中中心和其他19家综合... 详细信息

目的探讨球囊扩张或血管支架补救治疗对急性大脑中动脉M1段机械取栓治疗失败患者的安全性和有效性,并分析患者预后的影响因素。方法回顾性分析2014年1月至2018年6月中国人民解放军陆军军医大学第二附属医院综合卒中中心和其他19家综合卒中中心80例急性大脑中动脉M1段机械取栓治疗失败并行补救治疗达到闭塞血管血流改良脑梗死溶栓分级(modi?ed thrombolysis in cerebral infarction score,m TICI)≥2b级患者的临床资料,根据补救治疗方法将其分为球囊扩张组(30例)和血管支架植入组(50例)。比较两组患者90 d改良Rankin量表(modi?ed Rankin scale,m RS)评分、血管再闭塞率、症状性颅内出血发生率及死亡率,并对影响患者预后的相关因素进行多因素Logistic回归分析。结果球囊扩张组中90 d mRS评分0～2分患者占比明显高于血管支架植入组(P 0.05)。多因素Logistic回归分析显示:卒中病史(OR=8.968,95%CI:1.162～69.196,P=0.035)、补救治疗方式(OR=0.243,95%CI:0.066～0.894,P=0.033)、侧支循环(OR=3.873,95%CI:1.029～14.576,P=0.045)及基线美国国立卫生研究院卒中量表(National Institute of Health stroke scale,NIHSS)评分(OR=0.809,95%CI:0.701～0.934,P=0.004)均为急性大脑中动脉M1段闭塞取栓失败后行补救治疗患者神经功能预后的独立危险因素(P_均<0.05)。结论机械取栓联合球囊扩张能够有效改善急性大脑中动脉M1段闭塞性缺血性脑卒中患者神经功能,并未增加手术风险,且补救治疗方式是影响患者治疗后神经功能的独立危险因素。

关键词：急性缺血性脑卒中大脑中动脉M1段闭塞机械取栓球囊扩张血管支架植入